Cite
HARVARD Citation
Yue, Y. et al. (2023). Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]. Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yue, Y. et al. (2023). Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]. Leukemia research. p. . [Online].